The Royal Society of Chemistry is proud to announce that seven of the world's most influential scientists have been awarded ...
Findings from DEVOTE support clinical benefits of the high-dose regimen of nusinersen (50 mg and 28 mg) in both treatment-naïve individuals and ...
Ambry Genetics, a leader in clinical genomic testing, and now a wholly owned subsidiary of Tempus AI, Inc. , today announced its contribution to new research leveraging Multiplexed Assays of Variant ...